UNITY BIOTECHNOLOGY INC (UBX)
US91381U2006 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to UBX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 310.74% above the current price.
UBX was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about UBX.
In the previous month the buy percentage consensus was at a similar level.
UBX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-16 | Wedbush | Upgrade | Neutral -> Outperform |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-26 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-05-31 | Roth MKM | Initiate | Buy |
| 2023-05-26 | Citigroup | Maintains | Buy -> Buy |
| 2023-05-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-25 | Wedbush | Maintains | Outperform |
| 2023-03-28 | Mizuho | Maintains | Buy |
| 2023-03-28 | Wedbush | Maintains | Outperform |
| 2023-03-28 | Citigroup | Maintains | Buy |
| 2023-03-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-16 | Wedbush | Reiterate | Outperform |
| 2023-03-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-16 | Mizuho | Maintains | Buy |
| 2022-11-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-02 | Wedbush | Maintains | Outperform |
| 2022-08-16 | Mizuho | Maintains | Buy |
| 2022-08-15 | Citigroup | Maintains | Buy |
| 2022-05-17 | Citigroup | Maintains | Buy |
| 2022-01-04 | Roth Capital | Upgrade | Neutral -> Buy |
| 2021-11-10 | Mizuho | Upgrade | Neutral -> Buy |
| 2021-06-28 | Citigroup | Upgrade | Sell -> Buy |
| 2021-06-07 | HC Wainwright & Co. | Initiate | Buy |